4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users with a previous history of poor treatment response: a crossover trial

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Crack use has become a severe health problem in Brazil. Contingency management has shown robust evidence of efficacy in the treatment of cocaine use disorder (CUD) in high-income countries; however, it is still unclear how this intervention can impact treatment in low-income countries.

          Objective

          To evaluate the efficacy of contingency management in the treatment of CUD among individuals with a previous history of poor treatment response in Brazil.

          Methods

          Six months after the end of treatment, 32 participants previously allocated to the usual care condition (UCC) were invited to receive an additional 12 weeks of treatment in a contingency management condition (CMC), and 16 accepted the invitation. We compared data obtained from only the 16 participants (14 male) exposed to both treatment conditions.

          Results

          Participants attended more treatment sessions and were retained in treatment for a longer period during the CMC than during the UCC ( p < .01 for both). The proportion of negative cocaine samples submitted, the mean longest duration of cocaine abstinence, and the odds of being abstinent from cocaine during the 12 weeks of treatment were significantly higher during treatment in the CMC when compared to the UCC ( p < .05).

          Conclusions

          This study provides further evidence that contingency management is effective in promoting abstinence and retention in treatment among individuals with CUD with a history of poor treatment response. Our findings argue for the incorporation of CM among public treatment services for CUD in Brazil.

          Trial registration

          This study was registered at ClinicalTrials.gov as NCT01815645 on March 21, 2013.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

          To assess whether incentives improved treatment outcome in ambulatory cocaine-dependent patients. Forty cocaine-dependent adults were randomly assigned to behavioral treatment with or without an added incentive program. The behavioral treatment was based on the Community Reinforcement Approach and was provided to both groups. Subjects in the group with incentives received vouchers exchangeable for retail items contingent on submitting cocaine-free urine specimens during weeks 1 through 12 of treatment, while the group without incentives received no vouchers during that period. The two groups were treated the same during weeks 13 through 24. Seventy-five percent of patients in the group with vouchers completed 24 weeks of treatment vs 40% in the group without vouchers (P = .03). Average durations of continuous cocaine abstinence documented via urinalysis during weeks 1 through 24 of treatment were 11.7 +/- 2.0 weeks in the group with vouchers vs 6.0 +/- 1.5 weeks in the group without vouchers (P = .03). At 24 weeks after treatment entry, the voucher group evidenced significantly greater improvement than the no-voucher group on the Drug scale of the Addiction Severity Index (ASI), and only the voucher group showed significant improvement on the ASI Psychiatric scale. Incentives delivered contingent on submitting cocaine-free urine specimens significantly improve treatment outcome in ambulatory cocaine-dependent patients.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials.

            Clinical trials test the safety and efficacy of behavioral and pharmacological interventions in drug-dependent individuals. However, there is no consensus about the most appropriate outcome(s) to consider in determining treatment efficacy or on the most appropriate methods for assessing selected outcome(s). We summarize the discussion and recommendations of treatment and research experts, convened by the US National Institute on Drug Abuse, to select appropriate primary outcomes for drug dependence treatment clinical trials, and in particular the feasibility of selecting a common outcome to be included in all or most trials. A brief history of outcomes employed in prior drug dependence treatment research, incorporating perspectives from tobacco and alcohol research, is included. The relative merits and limitations of focusing on drug-taking behavior, as measured by self-report and qualitative or quantitative biological markers, are evaluated. Drug-taking behavior, measured ideally by a combination of self-report and biological indicators, is seen as the most appropriate proximal primary outcome in drug dependence treatment clinical trials. We conclude that the most appropriate outcome will vary as a function of salient variables inherent in the clinical trial, such as the type of intervention, its target, treatment goals (e.g. abstinence or reduction of use) and the perspective being taken (e.g. researcher, clinical program, patient, society). It is recommended that a decision process, based on such trial variables, be developed to guide the selection of primary and secondary outcomes as well as the methods to assess them. © 2011 Society for the Study of Addiction. No claim to original US government works.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reasons for dropout from drug abuse treatment: symptoms, personality, and motivation.

              Previous research has identified risk factors for early attrition from substance abuse treatment, but has not assessed reasons for dropout from the client's perspective. Interview and self-report assessment data were collected from 24 clients who prematurely terminated outpatient treatment to evaluate their subjective reasons for dropping out and the association of these reasons with demographic and clinical variables. Items from scales indicating problems with client motivation or conflicts with program staff were the most commonly endorsed. The severity of participant's symptoms and logistical problems interfering with appointments were less commonly reported as reasons for dropping out. Demographic, substance abuse, and motivational stage indicators were infrequently associated with subjective reasons for dropout. In contrast, indicators of maladaptive personality functioning were strongly associated with many reasons for dropping out, especially concerns about privacy and boundary issues within the program. Results from this preliminary evaluation will guide the development of an instrument and intervention focused on dropout risk factors and treatment reengagement.
                Bookmark

                Author and article information

                Contributors
                (+1) 203.508.5846 , (+1) 509.368.6896 , aqcmiguel@gmail.com , andre.miguel@wsu.edu
                (55) (011) 5084-7060 , claricesandi@gmail.com , pgpsiquiatria@psiquiatria.epm.br
                viviane.vivisimoes@gmail.com
                rodolfoyx@gmail.com
                claudiojeronimo@uniad.org.br
                mmcdonell@wsu.edu
                smcpherson05@wsu.edu
                johnroll@wsu.edu
                (55) (011) 5084-7060 , laranjeira@uniad.org.br , pgpsiquiatria@psiquiatria.epm.br , http://www.posgrad.epm.br/psiquiatria
                (55) (011) 5084-7060 , jamari17@gmail.com , pgpsiquiatria@psiquiatria.epm.br , http://www.posgrad.epm.br/psiquiatria
                Journal
                Psicol Reflex Crit
                Psicol Reflex Crit
                Psicologia, Reflexão e Crítica : revista semestral do Departamento de Psicologia da UFRGS
                Springer International Publishing (Cham )
                0102-7972
                1678-7153
                15 July 2019
                15 July 2019
                December 2019
                : 32
                : 14
                Affiliations
                [1 ]ISNI 0000 0001 0514 7202, GRID grid.411249.b, National Institute of Policies on Alcohol and Drugs (INPAD) of the Department of Psychiatry and Medical Psychology, , Federal University of São Paulo (UNIFESP), ; Rua: Dr. Diogo de Faria, 1036, 3º Andar–Vila Clementino, São Paulo, SP Brazil
                [2 ]ISNI 0000 0001 0514 7202, GRID grid.411249.b, Department of Psychiatry and Medical Psychology, , Federal University of São Paulo (UNIFESP), ; Rua Borges Lagoa, 570 – 1o andar – Vila Clementino, São Paulo, SP 04038-030 Brazil
                [3 ]ISNI 0000 0001 2157 6568, GRID grid.30064.31, Program of Excellence in Addictions Research, , Washington State University, ; P.O Box 1469, Spokane, WA USA
                [4 ]Spokane Valley, USA
                Article
                127
                10.1186/s41155-019-0127-2
                6967308
                838e432a-a79e-406e-8922-b8ae166503d6
                © The Author(s) 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

                History
                : 13 November 2018
                : 13 June 2019
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001807, Fundação de Amparo à Pesquisa do Estado de São Paulo;
                Award ID: 2011/01469-7
                Award ID: 2013/04138-7
                Award ID: 2017/05371-8
                Award ID: 2017/22004-9
                Funded by: FundRef http://dx.doi.org/10.13039/100000026, National Institute on Drug Abuse;
                Award ID: 5 U10 DA013714-10
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                crack cocaine,contingency management,behavior treatment,psychosocial treatment,brazil

                Comments

                Comment on this article